Literature DB >> 4623609

Separation of stages in the development of the "T" cells involved in cell-mediated immunity.

K Shortman, K T Brunner, J C Cerottini.   

Abstract

Density distribution analysis in continuous gradients of albumin has been used to study the development of cytotoxic lymphocytes (CL), to separate and characterize the progenitors of CL, and to determine their relationship to subpopulations of T cells. CL progenitors in the thymus were a homogeneous, medium-density population, distinct from the typical, dense, thymus small-lymphocyte. Activity seemed to be associated with one minor subpopulation of cells with surface antigenic properties characteristic of peripheral T cells (high levels of H-2 antigen, low levels of theta-antigen). CL progenitors in the spleen differed from those in the thymus and normally had the high buoyant density of typical small T lymphocytes. In states of antigenic stimulation, some lighter-density CL progenitors were found in the spleen. The buoyant density of the CL population developing in the spleens of immunized animals showed progressive changes with time. Early, "immature" CL had the light-density characteristics of large, activated lymphocytes. As the response developed, the density of the CL population increased, and finally approached that of CL progenitors and of typical small lymphocytes. The data suggest that density subpopulations of T cells represent stages in the development of immunocompetent cells. Possible differentiation pathways of T lymphocytes in the thymus and in the spleen are discussed.

Entities:  

Mesh:

Year:  1972        PMID: 4623609      PMCID: PMC2139177          DOI: 10.1084/jem.135.6.1375

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  A transplantable mast-cell neoplasm in the mouse.

Authors:  T B DUNN; M POTTER
Journal:  J Natl Cancer Inst       Date:  1957-04       Impact factor: 13.506

2.  Thymus-derived cells as killer cells in cell-mediated immunity.

Authors:  J F Miller; K T Brunner; J Sprent; P J Russell; G F Mitchell
Journal:  Transplant Proc       Date:  1971-03       Impact factor: 1.066

Review 3.  Current concepts of the immunological function of the thymus.

Authors:  J F Miller; D Osoba
Journal:  Physiol Rev       Date:  1967-07       Impact factor: 37.312

4.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors:  K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

5.  The density distribution of thymus, thoracic duct and spleen lymphocytes.

Authors:  K Shortman
Journal:  J Cell Physiol       Date:  1971-06       Impact factor: 6.384

6.  The separation of different cell classes from lymphoid organs. II. The purification and analysis of lymphocyte populations by equilibrium density gradient centrifugation.

Authors:  K Shortman
Journal:  Aust J Exp Biol Med Sci       Date:  1968-08

7.  Studies of allograft immunity in mice. I. Induction, development and in vitro assay of cellular immunity.

Authors:  K T Brunner; J Mauel; H Rudolf; B Chapuis
Journal:  Immunology       Date:  1970-04       Impact factor: 7.397

8.  Density distribution analysis of antigen-sensitive cells in the rat.

Authors:  J S Haskill
Journal:  J Exp Med       Date:  1969-10-01       Impact factor: 14.307

9.  Differentiation of antibody-forming cells in toad spleen. A study using density and sedimentation velocity cell separation.

Authors:  N Kraft; K Shortman
Journal:  J Cell Biol       Date:  1972-02       Impact factor: 10.539

10.  Cellular and humoral response to transplantation antigens. I. Development of alloantibody-forming cells and cytotoxic lymphocytes in the graft-versus-host reaction.

Authors:  J C Cerottini; A A Nordin; K T Brunner
Journal:  J Exp Med       Date:  1971-08-01       Impact factor: 14.307

View more
  16 in total

1.  Morphological definition of thymocyte subpopulations.

Authors:  A Matter
Journal:  Cell Tissue Res       Date:  1975       Impact factor: 5.249

2.  Populations of lymphocytes separated from human thymocytes.

Authors:  I M Roberts; S Whittingham; I R Mackay
Journal:  Clin Exp Immunol       Date:  1975-02       Impact factor: 4.330

3.  Properties of a subpopulation of T cells bearing histamine receptors.

Authors:  M Plaut; L M Lichtenstein; C S Henney
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

4.  Separation and characterization of cell subpopulations in the thymus.

Authors:  D Sabolović; F Dumont
Journal:  Immunology       Date:  1973-04       Impact factor: 7.397

5.  Two methods for detecting different aspects of the immune response to a xenograft in mice.

Authors:  E S Newlands
Journal:  Immunology       Date:  1974-10       Impact factor: 7.397

6.  Generation of cytotoxic T lymphocytes in vitro. III. Velocity sedimentation studies of the differentiation and fate of effector cells in long-term mixed leukocyte cultures.

Authors:  H R MacDonald; J C Cerottini; K T Brunner
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

7.  Electrophoretic mobility and surface immunoglobin of albumin gradient fractionated mouse spleen cells.

Authors:  F Dumont
Journal:  Immunology       Date:  1975-04       Impact factor: 7.397

8.  A cytophotometric and flow cytofluorometric approach to the differentiation of T lymphocytes in the thymus.

Authors:  A F Morselt; W Leene; J W Visser
Journal:  Histochemistry       Date:  1979-07

9.  Characterization of rat spleen-cell populations. I. Cell interactions in the regulation of in vitro response to concanavalin A.

Authors:  B Rocha; A Freitas; M de Sousa
Journal:  Immunology       Date:  1979-04       Impact factor: 7.397

10.  Lymphocytic choriomeningitis virus-induced immunosuppression: evidence for viral interference with T-cell maturation.

Authors:  A R Thomsen; K Bro-Jørgensen; B L Jensen
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.